Device type · FGB
Ureteroscope And Accessories, Flexible/Rigid
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
FGB
Gastroenterology & Urology
Device class
Class II
FDA decisions since 2015
70
510(k), De Novo and PMA
Adverse event reports
3,664
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Ureteroscope And Accessories, Flexible/Rigid
- Product code
- FGB
- Device class
- Class II
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.1500
- Specialty
- GI, Urology & Nephrology, Urology
- FDA record
- Classification database entry for FGB
Latest FDA decisions
The 8 newest of 70 since 2015.
Zhejiang Geyi Medical Instrument Co., Ltd.
K262437 · Decided Oct 29, 2026 · 105 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
K260708 · Decided Oct 20, 2026 · 230 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
- CVAC® Aspiration System510(k)
K261447 · Decided Sep 15, 2026 · 137 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
67 more FDA decisions with a free account
Reports received
3,664
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
3,613
99% of reports
Injury reports
48
1.3% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 33 | 51 | 1 | 0 |
| Jan 24 | 37 | 3 | 0 | 0 |
| Feb 24 | 29 | 11 | 0 | 0 |
| Mar 24 | 28 | 80 | 0 | 0 |
| Apr 24 | 39 | 4 | 0 | 0 |
| May 24 | 31 | 0 | 0 | 0 |
| Jun 24 | 42 | 4 | 0 | 0 |
| Jul 24 | 31 | 5 | 0 | 0 |
| Aug 24 | 37 | 5 | 0 | 0 |
| Sep 24 | 38 | 5 | 0 | 0 |
| Oct 24 | 58 | 0 | 0 | 1 |
| Nov 24 | 30 | 13 | 0 | 0 |
| Dec 24 | 33 | 8 | 0 | 0 |
| Jan 25 | 35 | 4 | 0 | 0 |
| Feb 25 | 44 | 0 | 0 | 0 |
| Mar 25 | 58 | 7 | 0 | 0 |
| Apr 25 | 51 | 5 | 0 | 0 |
| May 25 | 50 | 9 | 0 | 0 |
| Jun 25 | 76 | 7 | 0 | 0 |
| Jul 25 | 130 | 6 | 0 | 0 |
| Aug 25 | 162 | 0 | 0 | 0 |
| Sep 25 | 157 | 5 | 0 | 0 |
| Oct 25 | 137 | 3 | 0 | 0 |
| Nov 25 | 123 | 3 | 0 | 0 |
| Dec 25 | 245 | 3 | 0 | 0 |
| Jan 26 | 333 | 5 | 0 | 0 |
| Feb 26 | 260 | 6 | 0 | 0 |
| Mar 26 | 343 | 6 | 0 | 0 |
| Apr 26 | 422 | 3 | 0 | 0 |
| May 26 | 377 | 3 | 0 | 0 |
| Jun 26 | 306 | 6 | 0 | 0 |
| Jul 26 | 329 | 7 | 0 | 2 |
| Aug 26 | 337 | 3 | 0 | 0 |
| Sep 26 | 343 | 2 | 0 | 1 |
| Oct 26 | 195 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Aizu Olympus2,937
7 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Detachment of Device or Device Component894
- Loss of or Failure to Bond464
- Corroded362
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions3,572
- Insufficient Information60
- Urinary Tract Infection12
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3188-2026 · Started Jul 22, 2026 · Posted by FDA Sep 16, 2026
Reason given: A subset of power adapters used with the connect console may exhibit higher-than-expected resistance in the electrical grounding path. As a result, the power adaptor may fail electrical safety testing during installation.
Cause as FDA categorized it: Nonconforming Material/Component
- KARL STORZ - ENDOSKOPE, REF: 27003L, MICHEL Uretero-Renoscope, 9.5 Fr., 43cm, RxONLY, CE0123Open, Classified
Z-1051-2025 · Started Dec 19, 2024 · Posted by FDA Jan 30, 2025
Reason given: Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.
Cause as FDA categorized it: Labeling Change Control
Z-1052-2025 · Started Dec 19, 2024 · Posted by FDA Jan 30, 2025
Reason given: Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.
Cause as FDA categorized it: Labeling Change Control
25 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.